Jean-Marc A Lobaccaro Selected Research

Liver X Receptors

12/2020	Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.
8/2018	New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors.
7/2018	Retraction Note: Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
1/2017	Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
8/2014	Levels of liver X receptors in testicular biopsies of patients with azoospermia.
9/2013	Oxysterol receptors and their therapeutic applications in cancer conditions.
5/2013	Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.
1/2013	Lack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell.
1/2011	Dietary cholesterol-induced post-testicular infertility.
9/2009	LXR and ABCA1 control cholesterol homeostasis in the proximal mouse epididymis in a cell-specific manner.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Marc A Lobaccaro Research Topics

Disease

18	Neoplasms (Cancer) 12/2020 - 01/2013
14	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 01/2013
4	Infertility (Sterility) 02/2015 - 05/2007
3	Inflammation (Inflammations) 12/2020 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2020 - 04/2020
2	Neoplasm Metastasis (Metastasis) 07/2018 - 01/2017
2	Atherosclerosis 07/2015 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2011 - 05/2009
1	Breast Neoplasms (Breast Cancer) 05/2020
1	Glioblastoma (Glioblastoma Multiforme) 10/2018
1	Skin Diseases (Skin Disease) 10/2017
1	Carcinogenesis 01/2017
1	Obesity 02/2015
1	Rupture 09/2014
1	Nonobstructive Azoospermia 08/2014
1	Azoospermia 08/2014
1	Liver Diseases (Liver Disease) 12/2013
1	Hyperlipidemias (Hyperlipidemia) 04/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2013
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2013
1	Liver Neoplasms (Liver Cancer) 09/2012
1	Demyelinating Diseases (Demyelinating Disease) 06/2011
1	Ovarian Hyperstimulation Syndrome 07/2009
1	Choriocarcinoma 06/2008
1	Rickets (Rachitis) 12/2006
1	Osteoporosis 12/2006
1	Vitamin D Deficiency 12/2006
1	Osteomalacia 12/2006
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 12/2002
1	Hyperplasia 01/2002

Drug/Important Bio-Agent (IBA)

12	Liver X ReceptorsIBA 12/2020 - 01/2002
7	CholesterolIBA 09/2013 - 09/2009
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2020 - 07/2009
5	OxysterolsIBA 06/2011 - 01/2002
4	SteroidsIBA 05/2020 - 12/2013
4	Volatile Oils (Essential Oils)IBA 04/2020 - 01/2014
4	LipidsIBA 01/2017 - 05/2007
4	Proteins (Proteins, Gene)FDA Link 07/2015 - 06/2008
3	AndrogensIBA 12/2020 - 01/2018
3	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 12/2002
2	Estrogens (Estrogen)FDA Link 05/2020 - 03/2014
2	AntioxidantsIBA 10/2018 - 10/2017
2	Cholesterol Esters (Cholesteryl Esters)IBA 07/2015 - 05/2013
2	Bile Acids and Salts (Bile Acids)IBA 12/2013 - 03/2013
2	LigandsIBA 09/2013 - 12/2002
1	Estrogen ReceptorsIBA 05/2020
1	Plant ExtractsIBA 05/2020
1	Hormones (Hormone)IBA 05/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Insulin ReceptorIBA 01/2020
1	PhytochemicalsIBA 01/2020
1	Androgen Antagonists (Antiandrogens)IBA 01/2019
1	citral (neral)IBA 10/2018
1	Lipoxygenase (Lipoxygenase-1)IBA 10/2018
1	Propolis (Bee Bread)IBA 10/2017
1	Therapeutic UsesIBA 10/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	TensinsIBA 01/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 07/2015
1	Endocrine DisruptorsIBA 02/2015
1	Cadherins (E-Cadherin)IBA 09/2014
1	Connexin 43 (Connexin43)IBA 09/2014
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2013
1	oxysterol binding proteinIBA 09/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2013
1	Histone Deacetylase InhibitorsIBA 07/2013
1	Histones (Histone)IBA 05/2013
1	Lysine (L-Lysine)FDA Link 05/2013
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2013
1	TransferasesIBA 05/2013
1	Vitamin E FDA LinkGeneric 09/2012
1	Dietary CholesterolIBA 01/2011
1	Biological ProductsIBA 07/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2009
1	Secretory Phospholipases A2IBA 05/2009
1	EnzymesIBA 05/2009
1	T0901317IBA 06/2008
1	Messenger RNA (mRNA)IBA 06/2008
1	Vitamin D FDA LinkGeneric 12/2006
1	CalciumIBA 12/2006
1	Amino Acids FDA Link 12/2002

Therapy/Procedure

6	Therapeutics 12/2020 - 12/2013
3	Traditional Medicine (Folk Remedies) 04/2020 - 10/2018
2	Castration 01/2019 - 01/2018
1	African Traditional Medicine (Medicine, African) 01/2020
1	Chemoprevention 01/2020